Jacksoneye: the First Eye Clinic in Lake County or Wisconsin to Perform Lipiflow (FDA Approved)
Lipiflow (FDA Approved) Dry Eye Procedure
Jacksoneye is the pioneer eye clinic within the areas of Lake County or Wisconsin to be given the thumbs up approval from the FDA to perform this latest dry eye therapy treatment for patients with severe dry eye symptoms, the LipiFlow.
LipiFlow is a medial procedure intended to bring hope to all dry eye disease sufferers. It is perfect for treating adult patients diagnosed with MGD (Meibomian Gland Dysfunction), also known as “evaporative dry eye” or “lipid deficient dry eye”.
The LipiFlow treatment was aired on the episode of the Doctors “Fast Health Fixes” scheduled for viewing on May 6, 2013. Among the 100 million individuals worldwide who are reported to have acquired the dry eye problem, a big percentage have evaporative dry eye which is a lipid deficiency resulting from blockages in the meibomian glands found in the eyelids. The main function of these lipids is to prevent the tears (aqueous layer) of not evaporating quickly. Unlike the conventional methods of dry eye treatments such as warm compresses, eye drops and ointments used to solve the dry eye problem, the LipiFlow on the other hand goes deeper, the “real cause” of this clogging of the meibomian glands.
The purpose of LipiFlow is to unblock the glands and aid in the natural production of lipids which are necessary for healthy tear film. LipiFlow must only be performed by a certified eye doctor.
How LipiFlow works:
- A disposable eye piece is put to the patient’s eye where a certain amount of controlled heat is directly applied to the eyelid while gentle, intermittent pressure to the outer eyelid.
- LipiFlow procedure removes the blockage from the meibomian glands allowing the natural flow of lipids on its action.
- Entire process only takes 12 minutes and both eyes can be treated at the same time.
What to expect for a LipiFlow:
Based on a clinical study conducted, majority of patients who were treated through the LipiFlow technology reported successful results with a distinct improvement from any symptoms of dry eye after 4 weeks of treatment.
The actual procedure is only performed by Dr. Mitchell A. Jackson, a board-certified eye surgeon whose specialization is focused on cataract and refractive surgery. He is a credible ophthalmologist, finishing his medical degree at the Chicago Medical School, completing his internship at Columbus Hospital and earning his residency at the university of Chicago Hospitals. At present, Dr. Jackson is the founder and Medical director of the Jacksoneye, at the same time a clinical assistant of University of Chicago Hospitals.
About Dr. Jackson:
Dr. Mitchell Jackson has performed over 30,000 Lasik surgeries and 20,000 cataract surgeries since 1993. At present, he is also dedicated in teaching other physicians through courses being offered at the annual meetings of the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology. He is also a publisher of well-researched original articles, serves on 3 editorial boards and an international academic lecturer.
Jacksoneye is the leader in the use of laser technologies for cataract surgery, Lasik surgery, cataract lens replacement, contact lens implant, corneal transplant and glaucoma treatment. Jacksoneye is also the region’s leading referral center for MGD (Meibomian Gland Dysfunction), being Lake County’s only program for the prevention, diagnosis and cure of the evaporative dry eye and dysfunction.
Jacksoneye is centered in providing cutting-edge diagnostic and surgical facilities geared towards improving a patient’s visual condition.